Case Reports

Menin inhibition with revumenib clears measurable residual disease in acute myeloid leukemia with UBTF tandem duplication after allogeneic stem cell transplantation

Hematology Adolescents and Young Adults Unit, Saint Louis hospital, AP-HP, Paris
Hematology Biology, Saint Louis hospital, AP-HP, Paris
Hematology Biology, Saint Louis hospital, AP-HP, Paris
Hematology Adolescents and Young Adults Unit, Saint Louis hospital, AP-HP, Paris, France; Université Paris Cité, Inserm, Institut de Recherche Saint Louis (IRSL), F-75010 Paris
Hematology Biology, Saint Louis hospital, AP-HP, Paris, France; Université Paris Cité, Inserm, Institut de Recherche Saint Louis (IRSL), F-75010 Paris
Hematology Biology, Saint Louis hospital, AP-HP, Paris, France; Université Paris Cité, Inserm, Institut de Recherche Saint Louis (IRSL), F-75010 Paris
Hematology Adolescents and Young Adults Unit, Saint Louis hospital, AP-HP, Paris, France; Université Paris Cité, Inserm, Institut de Recherche Saint Louis (IRSL), F-75010 Paris
Hematology Adolescents and Young Adults Unit, Saint Louis hospital, AP-HP, Paris
Pediatric Oncology and Hematology Unit, Department of Oncology and Hematology, Santo Spirito Hospital, Pescara
Hematology Biology, Saint Louis hospital, AP-HP, Paris, France; Université Paris Cité, Inserm, Institut de Recherche Saint Louis (IRSL), F-75010 Paris
Hematology Adolescents and Young Adults Unit, Saint Louis hospital, AP-HP, Paris
Hematology Biology, Saint Louis hospital, AP-HP, Paris
Hematology Adolescents and Young Adults Unit, Saint Louis hospital, AP-HP, Paris
Hematology Adolescents and Young Adults Unit, Saint Louis hospital, AP-HP, Paris, France; Université Paris Cité, Inserm, Institut de Recherche Saint Louis (IRSL), F-75010 Paris
Hematology Biology, CHRU de Lille, Lille
Hematology Adolescents and Young Adults Unit, Saint Louis hospital, AP-HP, Paris
Haematologica Early view Oct 22, 2026 https://doi.org/10.3324/haematol.2026.301758